...
首页> 外文期刊>AJR: American Journal of Roentgenology : Including Diagnostic Radiology, Radiation Oncology, Nuclear Medicine, Ultrasonography and Related Basic Sciences >Utility of quantitative MRI metrics for assessment of stage and grade of urothelial carcinoma of the bladder: Preliminary results
【24h】

Utility of quantitative MRI metrics for assessment of stage and grade of urothelial carcinoma of the bladder: Preliminary results

机译:定量MRI指标用于评估膀胱尿路上皮癌的分期和等级的初步结果

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE. The purpose of this study was to assess associations between quantitative MRI metrics and pathologic indicators of aggressiveness of urothelial carcinoma of the bladder. MATERIALS AND METHODS. In this retrospective biinstitutional study, 37 patients (28 men and nine women; mean age, 73 ± 12 years) who underwent pelvic MRI including diffusion-weighted imaging (b values 0, 400, and 800 s/mm2) and T2-weighted imaging before transurethral resection or cystectomy for urothelial carcinoma of the bladder were identified. Tumor diameter (measured on T2-weighted imaging), normalized T2 signal intensity (to muscle; hereafter labeled normalized T2) and apparent diffusion coefficient (ADC) were measured for all tumors. Mann-Whitney test and receiver operating characteristic analyses were used to identify associations between these metrics and histopathologic tumor stage and grade. RESULTS. Thirty-seven tumors were assessed (mean size, 35 ± 23 mm; range 8-88 mm). At histopathologic analysis, 16 of 37 (43%) tumors were stage T2 or greater and 21 of 37 (57%) were stage T1 or lower, whereas 34 of 37 (92%) were high grade and three of 37 (8%) were low grade. High-stage (≥ T2) tumors showed greater tumor diameter, lower normalized T2, and lower ADC (p = 0.005-0.032) than low-stage (≤ T1) tumors. Tumor diameter and ADC were significant independent predictors of stage (p ≤ 0.043), with their combination giving an area-under the-curve (AUC) of 0.804. High-grade tumors showed significantly lower ADC (p = 0.023) but no significant difference in tumor diameter or normalized T2 (p = 0.201-0.559). AUC for differentiating low- And high-grade tumors was higher for ADC (0.902) than for tumor diameter (0.603) or normalized T2 (0.725). CONCLUSION. A combination of size and quantitative MRI metrics can potentially be used as markers of stage and grade of bladder cancer.
机译:目的。这项研究的目的是评估定量MRI指标和膀胱尿路上皮癌侵袭性的病理指标之间的关联。材料和方法。在这项回顾性双机构研究中,接受骨盆MRI检查的37例患者(男28例,女9例;平均年龄73±12岁)包括弥散加权成像(b值分别为0、400和800 s / mm2)和T2加权成像在经尿道切除或膀胱切除术治疗膀胱尿路上皮癌之前,已经确定。测量所有肿瘤的肿瘤直径(在T2加权成像上测量),归一化T2信号强度(对肌肉;下文标记为归一化T2)和表观扩散系数(ADC)。使用Mann-Whitney测试和接受者操作特征分析来确定这些指标与组织病理学肿瘤分期和等级之间的关联。结果。评估了37个肿瘤(平均大小35±23毫米;范围8-88毫米)。在组织病理学分析中,37个肿瘤中的16个(43%)为T2期或更高,37个肿瘤中的21个(57%)为T1或更低,而37个肿瘤中的34个(92%)为高分期,37个肿瘤中的三个(8%)是低年级。与低期(≤T1)肿瘤相比,高期(≥T2)肿瘤显示出更大的肿瘤直径,更低的标准化T2和更低的ADC(p = 0.005-0.032)。肿瘤直径和ADC是分期的重要独立预测因子(p≤0.043),它们的组合提供0.804的曲线下面积(AUC)。高度恶性肿瘤的ADC值显着降低(p = 0.023),但肿瘤直径或正常化的T2值无显着差异(p = 0.201-0.559)。 ADC(0.902)用于区分低度和高度肿瘤的AUC高于肿瘤直径(0.603)或标准化T2(0.725)。结论。大小和定量MRI指标的组合可以潜在地用作膀胱癌分期和等级的标志。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号